44.22
0.72 (1.66%)
Market Trend
Short Term | Medium Term | ||
Industry | Specialty Chemicals (US) | Mixed | Mixed |
Specialty Chemicals (Global) | Mixed | Mixed | |
Stock | Ingevity Corporation | Bearish | Bearish |
Stockmoo Score
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America. |
|
Sector | Basic Materials |
Industry | Specialty Chemicals |
Investment Style | Small Value |
52 Weeks Range | ||
Price Target Range | ||
High | 50.00 (Oppenheimer, 13.07%) | Buy |
Median | 47.50 (7.42%) | |
Low | 45.00 (Wells Fargo, 1.76%) | Hold |
Average | 47.50 (7.42%) | |
Total | 1 Buy, 1 Hold | |
Avg. Price @ Call | 43.07 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Oppenheimer | 01 Aug 2024 | 50.00 (13.07%) | Buy | 42.64 |
Wells Fargo | 11 Jul 2024 | 45.00 (1.76%) | Hold | 43.50 |
No data within this time range.
Date | Type | Details |
---|---|---|
11 Sep 2024 | Announcement | Ingevity to present and exhibit Capa® polycaprolactone at the FEICA European Adhesive and Sealant Conference and EXPO 2024 |
31 Jul 2024 | Announcement | Ingevity announces additional steps to advance strategic repositioning and improve profitability of its Performance Chemicals segment |
31 Jul 2024 | Announcement | Ingevity reports second quarter 2024 financial results |
18 Jul 2024 | Announcement | Ingevity announces dates for second-quarter 2024 earnings release and webcast |
17 Jul 2024 | Announcement | Ingevity names new general counsel and chief human resources officer to executive leadership team |
09 Jul 2024 | Announcement | Ingevity partners with Ultrapolymers Group for European sales of Capa® caprolactone Bioplastics |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |